Professor Jung Han was selected as one of 15 awardees for the 2025 Blavatnik Fund to develop a “Optical sensing solution for an accessible, non-invasive continuous blood glucose monitor (NIGM)”.
“NIGM is a holy grail in our digital health sector… we believe SWIR VCSELs are the missing puzzle piece.”
—VP, Tier 1 Consumer Digital Health Product OEM
“NIGM is a holy grail in our digital health sector… we believe SWIR VCSELs are the missing puzzle piece,” said the Engineering VP of a Tier 1 Consumer Digital Health Product OEM.
In addition to supporting this project with key SWIR VCSEL components. InPHRED is ready to provide the robust ecosystem and partnership to accelerate commercialization of this new NIGM technology.
The Blavatnik Fund for Innovation at Yale is a $65 million accelerator fund managed by Yale Ventures which has sponsored more than 90 unique projects leading to more than 20 startups and 4 acquisitions across drug and therapeutic discoveries, medical devices, digital health, and more.
InPHRED 